01/04/04

New findings give SARS vaccine hope

The SARS virus Copyright: WHO/The University of Hong Kong

We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:

You have to credit our authors.
You have to credit SciDev.Net — where possible include our logo with a link back to the original article.
You can simply run the first few lines of the article and then add: “Read the full article on SciDev.Net” containing a link back to the original article.
If you want to also take images published in this story you will need to confirm with the original source if you're licensed to use them.
The easiest way to get the article on your site is to embed the code below.

For more information view our media page and republishing guidelines.

The full article is available here as HTML.

Press Ctrl-C to copy

<div class="article-wrap">
<div id="article-introduction">
<h1>New findings give SARS vaccine hope</h1>
<h4></h4>
</div>
<br />
<br />

<div id="article-body">
<p><P>Researchers have developed a vaccine that they say offers protection against the virus that causes severe acute respiratory syndrome (SARS).</P><br />
<P>The vaccine, developed by scientists at the US National Institutes of Health, uses a small piece of the virus’s DNA to stimulate a protective response from the body’s immune system.</P><br />
<P>Experiments in mice, the results of which are published in this week’s <em>Nature</em>, show that the vaccine reduced the levels of virus in the animals’ lungs. The researchers now hope to carry out further experiments to evaluate the vaccine’s safety and test it in humans.</P><br />
<P><a  href="http://news.bbc.co.uk/1/hi/health/3586277.stm" target="_blank" onclick="pageTracker._trackPageview('/tracking/external/'+this.href);" rel="noopener noreferrer">Link to full BBC Online news story</A> </P><br />
<P><a  href="http://www.nature.com/login/scidev_login.taf?ref=/nature/journal/v428/n6982/full/nature02463_fs.html" target="_blank" onclick="pageTracker._trackPageview('/tracking/external/'+this.href);" rel="noopener noreferrer">Link to research paper by Zhi-yong Yang <EM>et al</EM> in <EM>Nature</EM></A> </P><br />
<P>Reference: <em>Nature</em> 428, 561 (2004)<BR><BR><EM>The National Institutes of Health has applied for patent protection (DHHS Reference Numbers E-228-2003, E-334-2003 and E-165-2004) on this and other SARS vaccines and is seeking commercial licensees to further develop these vaccines for commercial distribution for the ultimate benefit of the public health. Please contact Michael Shmilovich (email: <A href="/mailto:mish@codon.nih.gov">mish@codon.nih.gov</A>; tel: (301) 402-0220) for further information.</EM></P></p>

</div>
<div class="quick-links-wrapper">
<h3>You might also like</h3>
[related-articles]
</div>
<p>This article was originally published on <a href="https://www.scidev.net" target="_blank">SciDev.Net</a>. Read the <a href="https://www.scidev.net/global/news/new-findings-give-sars-vaccine-hope/" target="_blank">original article</a>.</p>
<script type="text/javascript">
(function(e,t,n,r,i,s,o){e["GoogleAnalyticsObject"]=i;e[i]=e[i]||function(){(e[i].q=e[i].q||[]).push(arguments)},e[i].l=1*new Date;s=t.createElement(n),o=t.getElementsByTagName(n)[0];s.async=1;s.src=r;o.parentNode.insertBefore(s,o)})(window,document,"script","//www.google-analytics.com/ga.js","ga");var _gaq=_gaq||[];var _gaq=_gaq||[];_gaq.push(["_setAccount","UA-3223906-8"],["_trackEvent","article interaction","republished","https://www.scidev.net/global/news/new-findings-give-sars-vaccine-hope/",null,true])
</script>
</div>

Researchers have developed a vaccine that they say offers protection against the virus that causes severe acute respiratory syndrome (SARS).

The vaccine, developed by scientists at the US National Institutes of Health, uses a small piece of the virus’s DNA to stimulate a protective response from the body’s immune system.

Experiments in mice, the results of which are published in this week’s Nature, show that the vaccine reduced the levels of virus in the animals’ lungs. The researchers now hope to carry out further experiments to evaluate the vaccine’s safety and test it in humans.

Link to full BBC Online news story

Link to research paper by Zhi-yong Yang et al in Nature

Reference: Nature 428, 561 (2004)

The National Institutes of Health has applied for patent protection (DHHS Reference Numbers E-228-2003, E-334-2003 and E-165-2004) on this and other SARS vaccines and is seeking commercial licensees to further develop these vaccines for commercial distribution for the ultimate benefit of the public health. Please contact Michael Shmilovich (email: [email protected]; tel: (301) 402-0220) for further information.